HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Influenza A/H1N1 virus in very low-birth-weight premature infant: case report.

Abstract
Influenza is an uncommon illness among premature infants in developed modern neonatal intensive care units (NICUs), but if infants do manifest symptoms of this significant illness, they commonly present with an abrupt onset, with temperature instability and upper respiratory tract involvement and, commonly, clinical features similar to bacterial sepsis. Additionally, frequent manifestations include bronchiolitis and pneumonia. Influenza infection in premature infants is likely a result of reduced levels of passively transferred protective maternal antibodies. Timely supportive therapy, antiviral agents, and isolation of affected infants to prevent spread of infection may be sufficient protective measures in the NICU. We report a case of a 50-day-old very low-birth-weight premature infant with novel A/H1N1 influenza virus (swine flu). There were no obvious epidemiological conditions in the NICU among patients and staff. The unique presenting symptom was apnea, which required respiratory support by nasal intermittent positive pressure ventilation. Due to the current pandemic, neonatologists should be aware of possible infection of neonates with novel A/H1N1 influenza virus.
AuthorsShay Barak, Amir Kushnir, Elena Chulski, Dany Miron
JournalAmerican journal of perinatology (Am J Perinatol) Vol. 27 Issue 7 Pg. 513-5 (Aug 2010) ISSN: 1098-8785 [Electronic] United States
PMID20091462 (Publication Type: Case Reports, Journal Article)
CopyrightCopyright Thieme Medical Publishers.
Chemical References
  • Antiviral Agents
  • Oseltamivir
Topics
  • Antiviral Agents (administration & dosage)
  • Apnea (therapy, virology)
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Infant, Premature, Diseases (diagnosis, immunology)
  • Infant, Very Low Birth Weight
  • Influenza A Virus, H1N1 Subtype
  • Influenza A virus
  • Influenza, Human (complications, diagnosis, immunology)
  • Intermittent Positive-Pressure Ventilation
  • Male
  • Oseltamivir (administration & dosage)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: